PortfoliosLab logoPortfoliosLab logo
GFI vs. CRMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GFI vs. CRMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gold Fields Limited (GFI) and CorMedix Inc. (CRMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GFI achieves a -13.96% return, which is significantly higher than CRMD's -24.85% return. Over the past 10 years, GFI has outperformed CRMD with an annualized return of 27.45%, while CRMD has yielded a comparatively lower -1.91% annualized return.


GFI

1D
1.67%
1M
-18.49%
YTD
-13.96%
6M
-13.63%
1Y
50.40%
3Y*
39.19%
5Y*
32.03%
10Y*
27.45%

CRMD

1D
-2.46%
1M
16.53%
YTD
-24.85%
6M
-23.93%
1Y
-41.18%
3Y*
15.11%
5Y*
1.21%
10Y*
-1.91%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GFI vs. CRMD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GFI
Gold Fields Limited
-13.96%240.42%-6.27%44.90%-2.61%23.33%43.02%89.47%-16.75%45.29%
CRMD
CorMedix Inc.
-24.85%43.58%115.43%-10.90%-7.25%-38.76%2.06%12.87%158.00%-67.32%

Correlation

The correlation between GFI and CRMD is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.06

Correlation (All Time)
Calculated using the full available price history since May 13, 2010

0.03

The correlation between GFI and CRMD shifts across timeframes, from 0.03 (all time) to 0.19 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GFI:

$32.65B

CRMD:

$812.69M

EPS

GFI:

$5.39

CRMD:

$2.10

PE Ratio

GFI:

6.78

CRMD:

4.16

PS Ratio

GFI:

2.34

CRMD:

1.88

PB Ratio

GFI:

3.87

CRMD:

1.86

Total Revenue (TTM)

GFI:

$13.98B

CRMD:

$400.05M

Gross Profit (TTM)

GFI:

$7.34B

CRMD:

$343.39M

EBITDA (TTM)

GFI:

$8.04B

CRMD:

$207.97M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GFI vs. CRMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GFI
GFI Risk / Return Rank: 6767
Overall Rank
GFI Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
GFI Sortino Ratio Rank: 6666
Sortino Ratio Rank
GFI Omega Ratio Rank: 6666
Omega Ratio Rank
GFI Calmar Ratio Rank: 6666
Calmar Ratio Rank
GFI Martin Ratio Rank: 6868
Martin Ratio Rank

CRMD
CRMD Risk / Return Rank: 1919
Overall Rank
CRMD Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
CRMD Sortino Ratio Rank: 2020
Sortino Ratio Rank
CRMD Omega Ratio Rank: 1818
Omega Ratio Rank
CRMD Calmar Ratio Rank: 1818
Calmar Ratio Rank
CRMD Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GFI vs. CRMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Gold Fields Limited (GFI) and CorMedix Inc. (CRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GFICRMDDifference
Sharpe ratioReturn per unit of total volatility

+1.45

Sortino ratioReturn per unit of downside risk

+1.96

Omega ratioGain probability vs. loss probability

1.18

0.92

+0.26

Calmar ratioReturn relative to maximum drawdown

1.15

-0.66

+1.82

Martin ratioReturn relative to average drawdown

3.06

-0.97

+4.03

GFI vs. CRMD - Sharpe Ratio Comparison

The current GFI Sharpe Ratio is 0.85, which is higher than the CRMD Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of GFI and CRMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GFI vs. CRMD - Drawdown Comparison

The maximum GFI drawdown since its inception was -88.05%, smaller than the maximum CRMD drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for GFI and CRMD.


Loading charts...

Drawdown Indicators


GFICRMDDifference

Max Drawdown

Largest peak-to-trough decline

-88.05%

-98.28%

+10.23%

Max Drawdown (1Y)

Largest decline over 1 year

-43.90%

-62.26%

+18.36%

Max Drawdown (3Y)

Largest decline over 3 years

-43.90%

-62.26%

+18.36%

Max Drawdown (5Y)

Largest decline over 5 years

-56.22%

-66.91%

+10.69%

Max Drawdown (10Y)

Largest decline over 10 years

-63.09%

-94.77%

+31.68%

Current Drawdown

Current decline from peak

-38.93%

-82.29%

+43.36%

Average Drawdown

Average peak-to-trough decline

-44.25%

-77.55%

+33.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.51%

42.56%

-26.05%

Volatility

GFI vs. CRMD - Volatility Comparison

Gold Fields Limited (GFI) has a higher volatility of 17.70% compared to CorMedix Inc. (CRMD) at 12.12%. This indicates that GFI's price experiences larger fluctuations and is considered to be riskier than CRMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GFICRMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.70%

12.12%

+5.58%

Volatility (6M)

Calculated over the trailing 6-month period

46.40%

51.58%

-5.18%

Volatility (1Y)

Calculated over the trailing 1-year period

59.94%

68.31%

-8.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

52.37%

77.11%

-24.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.90%

91.70%

-36.80%

Dividends

GFI vs. CRMD - Dividend Comparison

GFI's dividend yield for the trailing twelve months is around 5.04%, while CRMD has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CRMD
CorMedix Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GFI
Gold Fields Limited
5.04%1.77%2.94%2.87%3.40%3.24%1.72%0.81%1.61%1.41%1.35%0.60%

Financials

GFI vs. CRMD - Financials Comparison

This section allows you to compare key financial metrics between Gold Fields Limited and CorMedix Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B202120222023202420252026
5.29B
127.43M
(GFI) Total Revenue
(CRMD) Total Revenue
Values in USD except per share items

GFI vs. CRMD - Profitability Comparison

The chart below illustrates the profitability comparison between Gold Fields Limited and CorMedix Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-50.0%0.0%50.0%100.0%202120222023202420252026
56.7%
82.5%
Portfolio components
GFI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gold Fields Limited reported a gross profit of 3.00B and revenue of 5.29B. Therefore, the gross margin over that period was 56.7%.

CRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.

GFI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gold Fields Limited reported an operating income of 2.71B and revenue of 5.29B, resulting in an operating margin of 51.3%.

CRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.

GFI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gold Fields Limited reported a net income of 2.55B and revenue of 5.29B, resulting in a net margin of 48.2%.

CRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.


Frequently Asked Questions


GFI and CRMD have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GFI has higher volatility (17.70%) compared to CRMD (12.12%). In terms of maximum drawdown, GFI dropped -88.05% vs CRMD's -98.28%.

GFI currently has the higher Sharpe Ratio (0.85 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GFI and CRMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer